Nuvectis Pharma, Inc. Share Price

Nuvectis Pharma, Inc. Share Price

NASDAQ: NVCT | Small Cap
$18.54
-$0.05 (-0.3%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Nuvectis Pharma, Inc. Stock Performance

Open
$18.30
Prev. Close
$18.59
Circuit Range
N/A
Day Range
$18.30 - $18.71
Year Range
$5.65 - $29.18
Volume
11,585
Average Traded
$18.42

Nuvectis Pharma, Inc. Share Price Today

As of 31 October 2026, Nuvectis Pharma, Inc.'s share price is $18.54. The stock opened at $18.30, compared to its previous close of $18.59. During today's trading session, Nuvectis Pharma, Inc.'s share price traded between $18.30 and $18.71, with an average price of $18.51. Over the past 52 weeks, the stock has recorded a high of $29.18 and a low of $5.65. In terms of performance, Nuvectis Pharma, Inc.'s share price has risen by 116.34% over the last six months and is up 175.89% on a year-on-year basis.

Nuvectis Pharma, Inc. Share Price Chart

Line chart of the Nuvectis Pharma, Inc. price trend over the selected period. The price fell overall, ranging from 18.30 to 18.83, ending at 18.54.
$18.30$18.71
L
Show Current Price
H

Nuvectis Pharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$404.41M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.93
Revenue (TTM)
$0.00
Return On Equity (TTM)
-333.35%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
29.02%

Nuvectis Pharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$9.89-$7.31-$6.05-$7.02
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A26.09%17.24%-16.03%

Nuvectis Pharma, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$19.09-$22.26-$19.00-$28.87
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-16.61%14.65%-51.95%

About Nuvectis Pharma, Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

Nuvectis Pharma, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$21.29
$18.38
-13.30%
Sep 2026
$23.15
$21.20
-15.84%
Aug 2026
$21.80
$25.19
+17.63%
Jul 2026
$18.69
$21.41
+16.80%
Jun 2026
$9.82
$18.34
+87.09%
May 2026
$8.73
$9.80
+14.35%
Apr 2026
$7.83
$8.57
+11.01%
Mar 2026
$8.96
$7.72
-14.84%
Feb 2026
$8.27
$9.06
+11.65%
Jan 2026
$7.63
$8.12
+6.34%
Dec 2025
$6.28
$7.63
+22.55%
Nov 2025
$6.63
$6.23
-7.29%

NVCT Share Price FAQs